|
||||||
Nanotechnology patent delays bad for (almost) everyoneA story by Jon Van describes the growing backlog of nanotechnology patent applications:
It’s not just nanotech that’s feeling the pain:
The problem isn’t just the sheer number of applications:
Which brings up the question of whether the system is sustainable as technology accelerates and gets even more complex. It’s an arms race between well-funded private sector attorneys and government patent examiners. As soon as the latter get properly trained, they can make more money by becoming the former. How can correct decisions be made given this built-in imbalance? And it matters. These are 20-year monopolies being granted by the patent offices. Mistakes can be serious and costly, inhibiting investment. And that matters because, as regular readers know, nanotech looks very likely to bring major new cancer treatments, and later, “zero waste” manufacturing and excellent environmental remediation technologies. Some nanotech proponents would prefer some or all nanotechnologies — particularly those invented using taxpayer dollars — to be either public domain or under an open-source style license. But slow decisions from the patent office don’t further this goal either. They just create uncertainty. So is there anyone in favor of this mess? Those who are so anti-technology that they will even forgo an end to cancer, and give up the prospect of truly clean manufacturing, might approve of the situation. What’s the answer? First, let’s rethink the 20 year term. That’s even longer than it was 200 years ago, when inventions diffused much more slowly. Then let’s grapple seriously with the complexity issue. Is the current system viable long-term? If not, what makes more sense? —Christine 2 comments to Nanotechnology patent delays bad for (almost) everyone |
||||||
|
Copyright © 2010 the Foresight Institute - All Rights Reserved |
||||||
are their any bad points to nanotechnology?
[...] Questions: As nanotechnology appears in a growing number of products and patents, should the EPA move to regulate more than just nanosilver? What are the risks associated with proceeding with great caution and regulation with regards to emerging technologies? On the other hand, what are the risks associated with doing too little? [...]